Chief Administrative Officer and Global General Counsel · RESMED INC (RMD)

David Pendarvis

A named executive officer of RESMED in every fiscal year CompBrief holds from FY2016 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,857,556

Salary $578,911Stock awards $1,312,500

FY2018: $2,720,765

6th of 6 named executive officers at Resmed by FY2022 total.

6 named officers on file for RESMED, FY2022

David Pendarvis’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • RMD’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how RESMED’s whole pay program stands against its peers

  • RESMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 5, 2022 (DEF 14A).

Free

Get David Pendarvis’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Pendarvis compensation by year

RESMED Summary Compensation Table · all 4 fiscal years held
In US dollars, as RESMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2022
Salary$507,598$520,864$533,710$578,911
Bonus$0$0$0$0
Stock awards$1,103,437$1,591,953$1,275,000$1,312,500
Option awards$367,813$408,047$425,000$437,500
Non-equity incentive$374,189$350,724$390,861$444,926
Pension and deferred compensation$0$0$0$0
All other$58,640$63,299$96,194$83,719
Total$2,411,677$2,934,887$2,720,765$2,857,556

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RESMED INC DEF 14A filed October 5, 2022, accession 0000943819-22-000014, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RESMED INC filed document, accession 0000943819-22-000014. Every figure is read from that document and cited to the page and table it appears in. Filed October 5, 2022.

$2.4M
$2.9M
$2.7M
$2.9M
FY16
FY17
FY18
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU4,646$2,191,367—
RSU2,345$491,582—
PSU1,683$352,807—
PSU3,213$336,771—
RSU1,548$324,507—
PSU2,960$310,252—
RSU986$206,695—
Option5,233—$211.76
Option5,931—$263.16
Option4,408—$146.34

Per the Outstanding Equity Awards at Fiscal Year-End table in RESMED INC's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

RESMED’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Michael FarrellChief executive officer$11,659,210
Rob DouglasPresident and chief operating officer$6,320,744
Jim HollingsheadPresident – sleep and respiratory care business$3,196,792
Brett SandercockChief financial officer$2,891,395
Bobby GhoshalPresident - SaaS business$2,859,913
David Pendarvis · this pageChief Administrative Officer and Global General Counsel$2,857,556

The full RESMED compensation record

free company brief

This page is one person within RESMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RESMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RESMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Pendarvis's compensation dossier · One-time report. No refunds.